BIOG vs. FSV, GSS, CGT, BBGI, JPE, TRY, IEM, BRWM, RICA, and SAIN
Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include Fidelity Investment Trust - Fidelity Special Values (FSV), Genesis Emerging Markets Fund (GSS), Capital Gearing (CGT), BBGI Global Infrastructure (BBGI), JPMorgan Elect plc - Managed Growth (JPE), TR Property Investment Trust (TRY), Impax Environmental Markets (IEM), BlackRock World Mining Trust (BRWM), Ruffer Investment (RICA), and Scottish American Investment (SAIN). These companies are all part of the "asset management" industry.
The Biotech Growth Trust vs.
The Biotech Growth Trust (LON:BIOG) and Fidelity Investment Trust - Fidelity Special Values (LON:FSV) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, community ranking, institutional ownership and profitability.
In the previous week, The Biotech Growth Trust's average media sentiment score of 1.85 beat Fidelity Investment Trust - Fidelity Special Values' score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.
The Biotech Growth Trust has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, Fidelity Investment Trust - Fidelity Special Values has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.
Fidelity Investment Trust - Fidelity Special Values received 24 more outperform votes than The Biotech Growth Trust when rated by MarketBeat users. Likewise, 76.81% of users gave Fidelity Investment Trust - Fidelity Special Values an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote.
Fidelity Investment Trust - Fidelity Special Values has higher revenue and earnings than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Fidelity Investment Trust - Fidelity Special Values, indicating that it is currently the more affordable of the two stocks.
28.6% of The Biotech Growth Trust shares are owned by institutional investors. Comparatively, 64.8% of Fidelity Investment Trust - Fidelity Special Values shares are owned by institutional investors. 0.7% of The Biotech Growth Trust shares are owned by company insiders. Comparatively, 0.9% of Fidelity Investment Trust - Fidelity Special Values shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
The Biotech Growth Trust has a net margin of 95.33% compared to Fidelity Investment Trust - Fidelity Special Values' net margin of 94.33%. The Biotech Growth Trust's return on equity of 26.96% beat Fidelity Investment Trust - Fidelity Special Values' return on equity.
Summary
Fidelity Investment Trust - Fidelity Special Values beats The Biotech Growth Trust on 9 of the 14 factors compared between the two stocks.
Get The Biotech Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Biotech Growth Trust Competitors List
Related Companies and Tools
This page (LON:BIOG) was last updated on 2/22/2025 by MarketBeat.com Staff
Free BIOG Stock Alerts